Wellmune WGP enters Japanese market
Wellmune WGP is a natural ingredient designed to enhance key immune cells that help keep the body healthy. This natural beta 1,3/1,6 glucan from a proprietary strain of baker’s yeast is an ingredient in foods, beverage and supplements in more than 50 countries. Numerous peer-reviewed clinical studies provide strong support for the safety and efficacy of Wellmune WGP.
“Ryusendo is well established in the Japanese marketplace with strong customer relationships and highly trained sales force that excels at representing science-based specialty ingredients,” said Richard Mueller, CEO of Biothera. “Ryusendo is a great fit for Biothera and for Wellmune WGP.”
“Immune support is rapidly growing category spanning a broad range of consumers from infants to the elderly, and we are excited to make the immune health benefits of Wellmune available to the Japanese people,” said Yoshiaki Shiojima, CEO of Ryusendo.
